Perceptual omission errors in positron emission tomography and computed tomography reporting.


Journal

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
ISSN: 1827-1936
Titre abrégé: Q J Nucl Med Mol Imaging
Pays: Italy
ID NLM: 101213861

Informations de publication

Date de publication:
Mar 2023
Historique:
pubmed: 10 3 2021
medline: 21 3 2023
entrez: 9 3 2021
Statut: ppublish

Résumé

Omission errors in medical imaging can lead to missed diagnosis and harm to patients. The subject has been studied in conventional imaging, but no data is available for functional imaging in general and for PET/CT in particular. In this work, we evaluated the frequency and characteristics of perceptual omission errors in the PET component of oncologic PET/CT imaging, and we analyzed the hazardous scenarios prone to such modality-specific errors. Perceptual omission errors were collected in one tertiary center PET/CT clinic during routine PET/CT reporting over a 26-month period. The omissions were detected either in reporting follow-up PET/CT studies of the same patient or during multidisciplinary meetings. Significant omission errors were found in 1.2% of the 2100 reports included in the study. The most common omissions were bone metastases and focal colon uptake. We identified six PET-specific causative factors contributing to the occurrence of omissions, and we propose solutions to minimize their influence. The data presented here can help to promote the awareness of interpreting physicians to body areas that require higher attention and to implement reading strategies for improving the accuracy of PET/CT interpretation.

Sections du résumé

BACKGROUND BACKGROUND
Omission errors in medical imaging can lead to missed diagnosis and harm to patients. The subject has been studied in conventional imaging, but no data is available for functional imaging in general and for PET/CT in particular. In this work, we evaluated the frequency and characteristics of perceptual omission errors in the PET component of oncologic PET/CT imaging, and we analyzed the hazardous scenarios prone to such modality-specific errors.
METHODS METHODS
Perceptual omission errors were collected in one tertiary center PET/CT clinic during routine PET/CT reporting over a 26-month period. The omissions were detected either in reporting follow-up PET/CT studies of the same patient or during multidisciplinary meetings.
RESULTS RESULTS
Significant omission errors were found in 1.2% of the 2100 reports included in the study. The most common omissions were bone metastases and focal colon uptake. We identified six PET-specific causative factors contributing to the occurrence of omissions, and we propose solutions to minimize their influence.
CONCLUSIONS CONCLUSIONS
The data presented here can help to promote the awareness of interpreting physicians to body areas that require higher attention and to implement reading strategies for improving the accuracy of PET/CT interpretation.

Identifiants

pubmed: 33686849
pii: S1824-4785.21.03339-2
doi: 10.23736/S1824-4785.21.03339-2
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-82

Auteurs

Jeremy Godefroy (J)

Department of Nuclear Medicine and Biophysics, Hadassah Hebrew University Medical Center, Jerusalem, Israel - jeremyg@hadassah.org.il.

Simona Ben Haim (S)

Department of Nuclear Medicine and Biophysics, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Institute of Nuclear Medicine, University College London and UCL Hospitals, NHS Trust, London, UK.

Eyal Rosenbach (E)

Department of Nuclear Medicine and Biophysics, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Aaron N Meital (AN)

Department of Nuclear Medicine and Biophysics, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Adi Levy (A)

Department of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Alexandre Chicheportiche (A)

Department of Nuclear Medicine and Biophysics, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Rachel Bar-Shalom (R)

Department of Nuclear Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH